Technical Details

The SOLUTION SLR™ Drug-Eluting Balloon is a next-generation solution developed for coronary interventional procedures. It is designed for applications where treatment without leaving a metal stent may be preferred, including procedures addressing in-stent restenosis as well as small-vessel and bifurcation lesions. The balloon provides sustained limus release for up to 90 days. Cell Adherent Technology (CAT) supports effective adherence of drug particles to the vessel wall during inflation and is designed to minimize drug loss in the bloodstream. Its phospholipid blend and biocompatible polymer system support controlled drug storage and release through microreservoirs.

• ✓Sustained limus release for up to 90 days
• ✓Cell Adherent Technology (CAT)
• ✓Phospholipid and biocompatible polymer composition
• ✓Effective drug dose: 3 µg/mm²
• ✓Diameter range: 2.00 mm - 3.50 mm
• ✓Length range: 10 mm - 40 mm